Article Versions Notes

van der Sluis RJ, van den Aardweg T, Sijsenaar TJP, Van Eck M, Hoekstra M. Metyrapone Treatment Protects Low-Density Lipoprotein Receptor Knockout Mice against Hypercorticosteronemia Development without Changing Atherosclerosis Susceptibility. Biomolecules. 2023; 13(9):1287. https://doi.org/10.3390/biom13091287

van der Sluis, Ronald J., Tim van den Aardweg, Timothy J. P. Sijsenaar, Miranda Van Eck, and Menno Hoekstra. 2023. "Metyrapone Treatment Protects Low-Density Lipoprotein Receptor Knockout Mice against Hypercorticosteronemia Development without Changing Atherosclerosis Susceptibility" Biomolecules 13, no. 9: 1287. https://doi.org/10.3390/biom13091287

van der Sluis, R. J., van den Aardweg, T., Sijsenaar, T. J. P., Van Eck, M., & Hoekstra, M. (2023). Metyrapone Treatment Protects Low-Density Lipoprotein Receptor Knockout Mice against Hypercorticosteronemia Development without Changing Atherosclerosis Susceptibility. Biomolecules, 13(9), 1287. https://doi.org/10.3390/biom13091287